- Home
- OPHC vs BRNS Comparison
OPHC vs BRNS Comparison
Compare OPHC & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPHC | BRNS |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.8M | 55.9M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPHC | BRNS |
|---|---|---|
| Price | $5.01 | $0.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 32.2K | ★ 67.7K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.85 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $14,969,000.00 |
| Revenue This Year | $17,115.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.18 | ★ N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $3.76 | $0.56 |
| 52 Week High | $5.59 | $2.91 |
Technical Indicators
Market Signals| Indicator | OPHC | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 36.40 |
| Support Level | $4.00 | $0.56 |
| Resistance Level | $5.54 | $0.76 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 27.48 | 1.43 |
Price Performance
Historical ComparisonAbout OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.